Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Lisa Tans"'
Autor:
Maarten C. Dorr, Aniel Sewnaik, Elrozy Andrinopoulou, Diako Berzenji, Emilie A.C. Dronkers, Simone E. Bernard, Arta Hoesseini, Lisa Tans, Dimitris Rizopoulos, Robert J. Baatenburg de Jong, Marinella P.J. Offerman
Publikováno v:
Otolaryngology-Head and Neck Surgery, 168(6), 1463-1471. SAGE Publishing
OBJECTIVE: Patient-reported voice quality is an important outcome during counseling in early-stage glottic cancer. However, there is a paucity of adequate longitudinal studies concerning voice outcomes. This study aimed to investigate longitudinal tr
Autor:
Lukas B. Been, Olga Hamming-Vrieze, Sonja Levy, Lisa Tans, Mathilde Jalving, Alexander C.J. van Akkooi, Dirk J. Grünhagen, Stephanie A. Blankenstein, Margot E T Tesselaar
Publikováno v:
Radiotherapy and Oncology, 166, 203-211. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 166, 203-211. Elsevier Ireland Ltd
Radiotherapy and Oncology, 166, 203-211. Elsevier Ireland Ltd
BACKGROUND: Postoperative radiotherapy (PORT) is currently recommended for the treatment of Merkel cell carcinoma. Nevertheless, deviations occur frequently due to the generally elderly and frail patient population. We aimed to evaluate the influence
Autor:
Roel J H M Steenbakkers, Rob Kessels, Frank J. P. Hoebers, Lisa Tans, Olga Hamming-Vrieze, Cornelia G. Verhoef, Johannes H.A.M. Kaanders, Johannes A. Langendijk, Arash Navran, Francisca Ong, Erik van Werkhoven, Abrahim Al-Mamgani
Publikováno v:
Strahlentherapie Und Onkologie
Radiotherapy and Oncology, 149, 181-188. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 149, 181-188. Elsevier Ireland Ltd
Radiotherapy and oncology, 149, 181-188. Elsevier Ireland Ltd
Radiotherapy and Oncology, 149, pp. 181-188
Radiotherapy and Oncology, 149, 181-188
Radiotherapy and Oncology, 149, 181-188. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 149, 181-188. Elsevier Ireland Ltd
Radiotherapy and oncology, 149, 181-188. Elsevier Ireland Ltd
Radiotherapy and Oncology, 149, pp. 181-188
Radiotherapy and Oncology, 149, 181-188
Background: No randomized controlled trials (RCT) have yet identified the optimal palliative radiotherapy scheme in patients with incurable head and neck squamous cell carcinoma (HNSCC). We conducted RCT to compare two radiation schemes in terms of e
Autor:
Lisa Tans, Abrahim Al-Mamgani, Stefan L.S. Kwa, Jos B.W. Elbers, Fatma Keskin-Cambay, Aniel Sewnaik, Maarten Dorr, Remi Nout, Wilma Heemsbergen
Publikováno v:
Oral Oncology, 127:105782. Elsevier Ltd.
Objective: To validate the earlier reported promising oncologic outcomes and favorable toxicity profile following single vocal cord irradiation (SVCI) in an expanded cohort of patients with early-stage glottic cancer treated at our institute with lon
Autor:
Lisa Tans, S.L.S. Kwa, Aniel Sewnaik, R. Nout, Abrahim Al-Mamgani, M. Dorr, W. Heemsbergen, Fatma Keskin-Cambay
Publikováno v:
Radiotherapy and Oncology. 161:S604-S605
Autor:
Steven van de Water, Eleftheria Astreinidou, Augustinus D.G. Krol, Sebastiaan Breedveld, Fatma Keskin-Cambay, Lisa Tans, Martin A. de Jong, Mischa S. Hoogeman, R. Bijman, T. Arts
Publikováno v:
Radiotherapy and Oncology, 125(3), 520-525
Radiotherapy and Oncology, 125(3), 520-525. Elsevier Ireland Ltd
Radiotherapy and Oncology, 125(3), 520-525. Elsevier Ireland Ltd
Background and purpose The impact of treatment accuracy on NTCP-based patient selection for proton therapy is currently unknown. This study investigates this impact for oropharyngeal cancer patients. Materials and methods Data of 78 patients was used
Autor:
Sonja Levy, Olga Hamming-Vrieze, Alexander C.J. van Akkooi, Lukas B. Been, Lisa Tans, Dirk J. Grünhagen, Stephanie A. Blankenstein, Margot E T Tesselaar, Mathilde Jalving
Publikováno v:
Journal of Clinical Oncology. 39:9575-9575
9575 Background: MCC is a rare and aggressive neuroendocrine malignancy of the skin. Postoperative radiotherapy (PORT) is recommended by current guidelines to reduce recurrences and improve survival in patients with locoregional MCC. However, evidenc
Autor:
Abrahim Al-Mamgani, Peter van Rooij, Gerda M. Verduijn, Lisa Tans, S.L.S. Kwa, Robert Mehilal
Publikováno v:
European Archives of Oto-Rhino-Laryngology, 271(1), 125-132. Springer-Verlag
The objective of the presented study is to report on retrospectively collected data on long-term outcome and toxicity and prospective assessment of quality of life (QoL) and Voice-Handicap Index (VHI) of patients with T1a glottic cancer treated with
Publikováno v:
European Archives of Oto-Rhino-Laryngology
European Archives of Oto-Rhino-Laryngology, 270(1), 293-299. Springer-Verlag
European Archives of Oto-Rhino-Laryngology, 270(1), 293-299. Springer-Verlag
The optimal treatment of sinonasal undifferentiated carcinoma (SNUC) remains unclear. We report our results on the outcome and toxicity of patients with SNUC treated by a combined modality and attempt to define the optimal treatment strategies by rev
Autor:
Gerda M. Verduijn, Aniel Sewnaik, Peter van Rooij, Robert J. Baatenburg de Jong, Robert Mehilal, Lisa Tans, Abrahim Al-Mamgani
Publikováno v:
Oral Oncology, 49(10), 1018-1024. Elsevier Ltd.
Summary Objectives To compare outcome, toxicity and QoL of two boost modalities for T1-2 oropharyngeal carcinoma (OPC). Materials and methods Between 2000 and 2012, 250 consecutive patients with T1-2N0-3 were treated with 46-Gy of IMRT followed by bo